Presentation TCT 2016 RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso November 02, 2016
Presentation TCT 2016 ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation Presenter: Howard C. Herrmann, Robert J. de Winter, Hiroki Shiomi November 01, 2016
Presentation TCT 2016 FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu October 31, 2016
Presentation TCT 2016 FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo October 31, 2016
Presentation TCT 2016 MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth October 31, 2016
Presentation TCT 2016 FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid October 31, 2016
Presentation TCT 2016 REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley October 31, 2016
Presentation Stanford Coronary Physiology Conference 2016 Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial Presenter: William F. Fearon October 28, 2016
Presentation Stanford Coronary Physiology Conference 2016 FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies Presenter: Bernard De Bruyne October 28, 2016
Presentation Stanford Coronary Physiology Conference 2016 Assessing Chest Pain and Non-obstructive CAD Presenter: Jennifer A. Tremmel October 28, 2016
Presentation Stanford Coronary Physiology Conference 2016 FFR in Multivessel Disease: FAME-1 and Substudies Presenter: Nico H. J. Pijls October 28, 2016
Presentation ESC 2016 CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT) Presenter: John P. Greenwood August 29, 2016
Presentation Comparison of In-Hospital Mortality and Frequency of Coronary Angiography on Weekend vs Weekday Admissions in Patients With NSTEMI Presenter: Sahil Agrawal August 18, 2016
Presentation One-Year Outcomes of FFRCT-Guided Care in Patients With Suspected CAD Presenter: Pamela Douglas July 26, 2016
Presentation SOLACI 2016 Uso de Softwares e Técnicas De Realce Angiográfico Presenter: Silvio Gioppato June 09, 2016
Presentation SOLACI 2016 The Role of Ischemia, Complete Revascularization and Intravascular Imaging in Contemporary PCI Presenter: Ajay J. Kirtane June 09, 2016
Presentation SOLACI 2016 Intracoronary Ultrasound What Have We Learned Since Colombo to Now ? Presenter: Costantino Costatini June 09, 2016
Presentation SOLACI 2016 Reserva Fracionada de Fluxo na Avaliação da Doença Coronariana Multivascular Complexa Presenter: Cesar R. Medeiros June 08, 2016
Presentation SOLACI 2016 New Stent Platforms & Daily Practice Case Presentation Presenter: Oscar A. Mendiz June 08, 2016
Presentation SOLACI 2016 Is digital angiography (QCA) still a useful tool in the clinical practice? Presenter: Ricardo Cavalcante e Silva June 08, 2016